Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety

Authors

Institutions

Publication Details

Journal
Therapeutic Advances in Gastroenterology
Published
2026-02-01
DOI
https://doi.org/10.1177/17562848251406092
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety

Miroslava Volfová, Milan Lukáš, Grażyna Rydzewska, Shashi Adsul et al.
Therapeutic Advances in Gastroenterology
Inflammatory Bowel Disease
article

Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety

Miroslava Volfová, Milan Lukáš, Grażyna Rydzewska, Shashi Adsul, Stephen Jones, Séverine Vermeire, Dirk Lindner, Silvio Danese
article en

Abstract

No abstract available for this paper.
Therapeutic Advances in GastroenterologyVol. 19
Vita-Salute San Raffaele University (IT), Takeda (Switzerland) (CH), Iscare I.V.F (CZ), Ministry of Interior and Administration (PL), University Hospital Hradec Králové (CZ), Takeda (United States) (US), KU Leuven (BE)
Openalex Percentile: Top 59%
Inflammatory Bowel Disease
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.